Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure.

PubWeight™: 1.86‹?› | Rank: Top 3%

🔗 View Article (PMID 11799087)

Published in Hypertension on January 01, 2002

Authors

Robert J Glynn1, Gilbert J L'Italien, Howard D Sesso, Elizabeth A Jackson, Julie E Buring

Author Affiliations

1: Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215-1204, USA. rglynn@rics.bwh.harvard.edu

Associated clinical trials:

Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer (WHS) | NCT00000479

Articles citing this

C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation (2008) 7.33

Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study. Circulation (2008) 3.16

Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation (2009) 2.26

Chimney stove intervention to reduce long-term wood smoke exposure lowers blood pressure among Guatemalan women. Environ Health Perspect (2007) 2.23

Systolic blood pressure levels among adults with hypertension and incident cardiovascular events: the atherosclerosis risk in communities study. JAMA Intern Med (2014) 2.05

Discovery and replication of novel blood pressure genetic loci in the Women's Genome Health Study. J Hypertens (2011) 1.81

Blood pressure and vascular calcification. Hypertension (2010) 1.68

Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ (2007) 1.40

Does chocolate reduce blood pressure? A meta-analysis. BMC Med (2010) 1.25

The relationship between systolic blood pressure on admission and mortality in older patients with heart failure. Eur J Heart Fail (2010) 1.12

Retracted The significance of the j-curve in hypertension and coronary artery diseases. Korean Circ J (2011) 1.10

Prediction of incident hypertension risk in women with currently normal blood pressure. Am J Med (2009) 0.93

Efficacy of a brief multifactorial adherence-based intervention on reducing the blood pressure of patients with poor adherence: protocol for a randomized clinical trial. BMC Cardiovasc Disord (2010) 0.84

30 Year patterns of mortality in Tobago, West Indies, 1976-2005: impact of glucose intolerance and alcohol intake. PLoS One (2011) 0.83

Current status of aggressive blood pressure control. World J Cardiol (2011) 0.81

Comparison of blood pressure measurements using an automated blood pressure device in community pharmacies and family physicians' offices: a randomized controlled trial. CMAJ Open (2013) 0.80

Residual Cardiovascular Risk in Individuals on Blood Pressure-Lowering Treatment. J Am Heart Assoc (2015) 0.79

Assessing Sex Differences in the Risk of Cardiovascular Disease and Mortality per Increment in Systolic Blood Pressure: A Systematic Review and Meta-Analysis of Follow-Up Studies in the United States. PLoS One (2017) 0.79

Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in Greece. Eur J Health Econ (2010) 0.78

Sedentary behavior and blood pressure control among osteoarthritis initiative participants. Osteoarthritis Cartilage (2014) 0.78

Blood pressure targets in the treatment of high blood pressure: a reappraisal of the J-shaped phenomenon. J Hum Hypertens (2013) 0.77

Is it a new approach for treating senile hypertension with kidney-tonifying chinese herbal formula? A systematic review of randomized controlled trials. Evid Based Complement Alternat Med (2014) 0.76

Cost-effectiveness of amlodipine compared with valsartan in preventing stroke and myocardial infarction among hypertensive patients in Taiwan. Int J Gen Med (2016) 0.75

New insights into the management of hypertension and cardiovascular risk with Angiotensin receptor blockers: observational studies help us? Open Cardiovasc Med J (2014) 0.75

Risk for Incident Heart Failure: A Subject-Level Meta-Analysis From the Heart "OMics" in AGEing (HOMAGE) Study. J Am Heart Assoc (2017) 0.75

Articles by these authors

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA (2007) 15.32

Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 12.09

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA (2007) 9.68

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 9.03

Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation (2004) 7.77

Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ (2007) 7.54

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation (2003) 6.99

Migraine and risk of cardiovascular disease in women. JAMA (2006) 6.16

Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med (2009) 6.16

Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med (2009) 6.00

Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med (2007) 5.95

Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA (2008) 5.92

Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med (2002) 5.80

C-reactive protein and the risk of developing hypertension. JAMA (2003) 5.75

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA (2005) 5.74

The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med (2006) 5.69

Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol (2008) 5.28

Physical activity and weight gain prevention. JAMA (2010) 5.27

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26

Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 5.25

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14

Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 5.13

Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med (2010) 5.05

Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ (2009) 4.98

Inactivating mutations in NPC1L1 and protection from coronary heart disease. N Engl J Med (2014) 4.94

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89

Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA (2011) 4.73

Association between a literature-based genetic risk score and cardiovascular events in women. JAMA (2010) 4.46

Prevalence of dry eye syndrome among US women. Am J Ophthalmol (2003) 4.46

Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women. Clin Chem (2007) 4.45

Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 4.40

Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet (2008) 4.31

Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation (2009) 3.93

Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81

Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69

Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation (2011) 3.68

Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol (2006) 3.41

Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37

A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med (2007) 3.37

Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA (2004) 3.31

Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. Eur Heart J (2007) 3.21

Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation (2007) 3.20

A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med (2006) 3.19

Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat Genet (2009) 3.06

Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation (2008) 3.03

Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr (2002) 3.00

Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA (2006) 2.99

The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study). J Am Coll Cardiol (2010) 2.96

Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med (2007) 2.95

Body mass index and the risk of stroke in men. Arch Intern Med (2002) 2.90

Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med (2008) 2.90

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89

Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care (2005) 2.89

Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry). Am J Cardiol (2002) 2.82

Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study. Arch Intern Med (2009) 2.81

C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med (2005) 2.79

A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease. Cancer Epidemiol Biomarkers Prev (2007) 2.77

Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA (2005) 2.76

Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation (2005) 2.73

Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation (2003) 2.73

Exceptional longevity in men: modifiable factors associated with survival and function to age 90 years. Arch Intern Med (2008) 2.67

Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. Arch Ophthalmol (2009) 2.65

Migraine and risk of haemorrhagic stroke in women: prospective cohort study. BMJ (2010) 2.63

The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials (2011) 2.59

A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: the women's health study. Diabetes Care (2004) 2.57

Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev (2013) 2.56

Migraine and risk of cardiovascular disease in men. Arch Intern Med (2007) 2.49

Relative intensity of physical activity and risk of coronary heart disease. Circulation (2003) 2.49

Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ (2008) 2.48

Migraine frequency and risk of cardiovascular disease in women. Neurology (2009) 2.47

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45

New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatment-eligible population. Circulation (2002) 2.44

Migraine and coronary heart disease in women and men. Headache (2002) 2.44

Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes (2012) 2.43

A prospective study of body mass index and the risk of developing hypertension in men. Am J Hypertens (2007) 2.43

Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation (2006) 2.40

Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Ann Intern Med (2013) 2.39

Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med (2013) 2.33

Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. JAMA (2008) 2.32

Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women. Clin Chem (2009) 2.31

Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis (2005) 2.30

Birth weight is a significant risk factor for incident atrial fibrillation. Circulation (2010) 2.30

Dietary fat types and 4-year cognitive change in community-dwelling older women. Ann Neurol (2012) 2.29

Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women. JAMA (2006) 2.27

Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation (2009) 2.26

Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes. Am J Clin Nutr (2010) 2.25

C-reactive protein in the prediction of rheumatoid arthritis in women. Arch Intern Med (2006) 2.22

Blood pressure in early adulthood, hypertension in middle age, and future cardiovascular disease mortality: HAHS (Harvard Alumni Health Study). J Am Coll Cardiol (2011) 2.20